[Ip-health] The George Institute for International Health

[wshahid@haverford.edu]

The George Institute for International Health is a non-profit entity
that does research on health policy.  The George Institute has received
significant funding from the Bill and Melinda Gates Foundation to review
global investments in neglected diseases. (http://bit.ly/BtYri)

The George Institute also receives funding from several private
companies, including but not limited to the following:

AMGEN (biotech firm)
AstraZeneca (pharmaceutical company)
Aventis (pharmaceutical company, created when Rhone-Pouleenc merged with
Hoechst)
Bayer (pharmaceutical)
Boehringer Ingelheim through the Hamilton Health Sciences Corporation,
McMaster University, Canada (pharmaceutical)
Bristol-Myers Squibb (biopharmaceutical)
Compumedics Ltd (medical technology)
CSL Behring (biopharmaceutical)
DiagnoseIT (biotech)
Fisher & Paykel Healthcare Corporation Ltd (biotech)
Glaxo Wellcome (pharmaceutical)
Guidant Corporation (biotech)
Hoechst (pharmaceutical, became Aventis, then became Sinofi-Aventis)
Merck (pharmaceutical)
Novartis (pharmaceutical)
Pfizer (pharmaceutical)
ResMed Inc (biotech)
Respironics (biotech)
Sanofi-Aventis (pharmaceutical, created when Sanofi-Synthelabo purchased
Aventis)
Sanofi-Synthelabo (pharmaceutical, created when Sanofi merged with
Synthelabo, then became Sanofi-Aventis)
Searle (pharmaceutical, preceeded Pfizer)
Servier (pharmaceutical)